ArticleClinical drug investigation2020

Cost-effectiveness Analysis of CYP2D6*10 Pharmacogenetic Testing to Guide the Adjuvant Endocrine Therapy for Postmenopausal Women with Estrogen Receptor Positive Early Breast Cancer in China.

Xiaoxia Wei et al.PubMed ↗Publisher ↗

No numbers read from the abstract.